Trading Signals: CGEN Stock Price Prediction and Forecast (Wed. Jun. 11, 2003 - Fri. May. 13, 2022)(Compugen Ltd.)
| CGEN latest price $7.8600 (-2.42%) ($7.8600 - $7.8600) on Mon. Mar. 29, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.04% (three month average) | RSI | 45 | Latest Price | $7.8600(-2.42%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CGEN declines -3% a day on average for past five trading days. | Weekly Trend | CGEN declines -4.3% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support CGEN advance at 0% a week (0% probability) XBI(71%) ARKG(69%) ARKK(65%) IWO(64%) IBB(62%) | Factors Impacting CGEN price | CGEN will decline at least -2.52% in a week (0% probabilities). VIXM(-45%) VXX(-38%) UUP(-19%) IGOV(-14%) TLT(-5%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.52% (StdDev 5.04%) | Hourly BBV | -0.9 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-4.16(-152.93%) | Resistance Level | $8.64 | 5 Day Moving Average | $8.19(-4.03%) | 10 Day Moving Average | $8.58(-8.39%) | 20 Day Moving Average | $8.64(-9.03%) | To recent high | -43.1% | To recent low | 3.1% | Market Cap | $650m | | | | Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. |